US President Donald Trump just stated from the White House that he would sign fresh agreements with nine pharmaceutical companies to lower the cost of some medicines.

These treatments are included in a list of those that Medicaid recipients can order legally. The president predicted that drug charges in the United States will significantly decrease starting next year and will soon be the lowest in the developed world. Trump stated that he intends to offer tax deductions for at least three years, as long as commitments to keep prices low are kept in place, in order to accomplish this goal. Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi will be listed among the pharmaceutical companies that will offer discounts on prescription drugs through TrumpRx, a website designed to help people buy prescription drugs at lower rates. Additionally, the drugs that will be covered by the deductions include those that are used to treat chronic conditions like rheumatoid arthritis, multiple sclerosis, asthma, chronic obstructive pulmonary disease, hepatitis B and C, human immunodeficiency virus, and some types of cancer.

Prior to now, drug costs were 30 % to 40 % higher in other countries than those in other countries. These agreements aim to bring Americans ' access to affordable medical and dignified access to medical advances on par with those in another developed nations.

This news has been tken from authentic news syndicates and agencies and only the wordings has been changed keeping the menaing intact. We have not done personal research yet and do not guarantee the complete genuinity and request you to verify from other sources too.